Cancer Letters
Volume 206, Issue 2 , Pages 129-135 , 8 April 2004

Green fluorescent protein as a tool to study epidermal growth factor receptor function

Received 24 July 2003 ,Accepted 7 August 2003.

References 

  1. In:  Sullivan KF,  Kay SA editor. Methods in Cell Biology. vol. 58:1999;
  2. Baird GS, Zacharias DA, Tsien RY. Biochemistry, mutagenesis and oligomerization of DsRed, a red fluorescent protein from coral. Proc. Natl Acad. Sci. USA 97. 2000;11984–11989
  3. Gurskaya NG, Fradkov AF, Terskikh A, Matz MV, Labas YA, Martynov VI, et al.  GFP-like chromoproteins as a source of far-red fluorescent proteins. Fed. Eur. Biochem. Soc. Lett. 2001;507:16–20
  4. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, et al. A monomeric red fluorescent protein. Proc. Natl Acad. Sci. USA 99. 2002;7877–7882
  5. Fradkov AF, Verkhusha VV, Staroverov DB, Bulina ME, Yanushevich YG, Martynov VI, et al.  Far-red fluorescent tag for protein labeling. Biochem. J. 2002;368:17–21
  6. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, et al. A monomeric red fluorescent protein. Proc. Natl Acad. Sci. USA 99. 2002;7877–7882
  7. Hahn K, Toutchkine A. Live-cell fluorescent biosensors for activated signaling proteins. Curr. Opin. Cell. Biol. 2002;14:167–172
  8. Wouters FS, Bastiaens PIH. Fluorescence lifetime imaging of receptor tyrosine kinase activity in cells. Curr. Biol. 1999;9:1127–1130
  9. Lippincott-Schwartz J, Snapp E, Kenworthy A. Studying protein dynamics in living cells. Nat. Rev. Mol. Cell. Biol. 2001;6:444–456
  10. Yarden Y, Sliwkowski MX. Untangling the ErbB signaling network. Nat. Rev. Mol. Cell. Biol. 2001;2:127–137
  11. Gullick WJ. The Type 1 growth factor receptors and their ligands considered as a complex system. Endocr-Relat. Cancer. 2001;8:75–82
  12. Jahn T, Seipel P, Coutinho S, Urschel S, Schwarz K, Miething C, et al.  Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain. Oncogene. 2002;21:4508–4520
  13. Carter RE, Sorkin A. Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera. J. Biol. Chem. 1998;273:35000–35007
  14. Simske JS, Kaech SM, Harp SA, Kim SK. LET-23 receptor localization by the cell junction protein LIN-7 during C-elegans vulval induction. Cell. 1996;85:195–204
  15. Jorissen RN, Walker F, Pouliot N, Garrett TPJ, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanism of activation and signaling. Exp. Cell Res. 2003;284:31–53
  16. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992;360:689–692
  17. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70:431–442
  18. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, et al.  Guanine-nucleotide-releasing factor hSOS1 binds GRB2 and links receptor tyrosine kinases to ras signaling. Nature. 1993;363:85–88
  19. Sorkin A, McClure M, Huang FT, Carter R. Interaction of EGF receptor and Grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr. Biol. 2000;10:1395–1398
  20. Wouters FS, Verveer PJ, Bastiaens PIH. Imaging biochemistry inside cells. Trends. Cell. Biol. 2001;11:203–211
  21. Carter RE, Sorkin A. Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera. J. Biol. Chem. 1998;273:35000–35007
  22. Prigent SA, Gullick WJ. Identification of c-ErbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using and EGF receptor/c-erbB-3 chimera. Eur. Mol. Biol. Org. J. 1994;13:2831–2841
  23. Gillham H, Golding MC, Pepperkok R, Gullick WJ. Intracellular movement of green fluorescent protein-tagged phosphatidylinositol 3-kinase in response to growth factor receptor signaling. J. Cell. Biol. 1999;146:869–880
  24. Venkateswarlu K, Gunn-Moore F, Oatey PB, Tavare JM, Cullen PJ. Nerve growth factor- and epidermal growth factor-stimulated translocation of the ADP ribosylation factor exchange factor GRP1 to the plasma membrane of PC12 cells requires activation of phosphatidylinositol 3-kinase and the GRP1 pleckstrin homology domain. Biochem. J. 1998;335:139–146
  25. Venkateswarlu K, Gunn-Moore F, Tavare JM, Cullen PJ. EGF-and NGF-stimulated translocation of cytohesin-1 to the plasma membrane of PC12 cells requires PI 3-kinase activation and a functional cytohesin-1 PH domain. J. Cell. Sci. 1999;112:1957–1965
  26. Watton SJ, Downward J. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell–cell interaction. Curr. Biol. 1999;9:433–436
  27. Lockyer PJ, Wennstrom S, Kupzig S, Venkateswarlu K, Downward J, Cullen PJ. Identification of the ras GTPase-activating protein GAP1(m) as a phosphatidylinositol-3,4,5-trisphosphate protein in vivo. Curr. Biol. 1999;9:265–268
  28. Sorkin A, McClure M, Huang F, Carter R. Interaction of EGF receptor and Grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr. Biol. 2000;10:1395–1398
  29. Yamazaki T, Zaal K, Hailey D, Presley J, Lippincott-Schwartz J, Samelson LE. Role of Grb2 in EGF-stimulated EGFR internalization. J. Cell. Sci. 2002;115:1791–1802
  30. Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science. 1996;274:2086–2089
  31. Wilde A, Beattie EC, Lem L, Riethof DA, Liu SH, Mobley WC, et al. EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin influencing clathrin redistribution and EGF uptake. Cell. 1999;96:677–687
  32. Jiang X, Huang F, Marusyk A, Sorkin A. Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol. Biol. Cell. 2003;14:858–870
  33. Wang XJ, Liao HJ, Chattopadhyay A, Carpenter G. EGF-dependent translocation of green fluorescent protein-tagged PLC-gamma 1 to the plasma membrane and endosomes. Exp. Cell. Res. 2001;267:28–36
  34. Sato K, Sato A, Aoto M, Fukami Y. Site-specific association of c-Src with epidermal growth factor receptor in A431 cells. Biochem. Biophys. Res. Commun. 1995;210:844–851
  35. Sato K, Sato A, Aoto M, Fukami Y. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem. Biophys. Res. Commun. 1995;215:1087–1087
  36. Stover DR, Becker M, Liebetanz J, Lydon NB. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. J. Biol. Chem. 1995;270:15591–15597
  37. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 1999;274:8335–8343
  38. Sato K, Kimoto M, Kakumoto M, Horiuchi D, Iwasaki T, Tokmakov AA, et al. Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells. Genes Cells. 2000;5:749–764
  39. Bustelo XR. The VAV family of signal transduction molecules. Crit. Rev. Oncog. 1996;7:65–88
  40. Pandey A, Podtelejnikov AV, Blagoev B, Bustelo XR, Mann M, Lodish HF. Analysis of receptor signaling pathways by mass spectrometry: identification of Vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc. Natl Acad. Sci. USA 97. 2000;179–184
  41. Tamas P, Solti Z, Buday L. Membrane-targeting is critical for the phosphorylation of Vav2 by activated EGF receptor. Cell Signal. 2001;13:475–481
  42. Lamb RF, Hennigan R, Turnball K, Katsanakis KD, MacKenzie ED, Birnie GD, et al. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol. 1997;17:963–976
  43. Baselga J, Albanell J. Mechanism of action of anti-HER2 monoclonal antibodies. Ann. Oncol. 2001;12:35–41 Suppl
  44. Baselga J, Albanell J, Molina MA, Arribas J. Mechanism of action of trastuzumab and scientific update. Semin. Oncol. 2001;28:4–11 Suppl.
  45. Citri A, Alroy I, Lavi S, Rubin C, Xu W, Grammatikakis N, et al.  Drug-induced ubiquitylation and degredation of ErbB receptor tyrosine kinases: implications for cancer therapy. Eur. Mol. Biol. Org. J. 2002;21:2407–2417
  46. Wu X, Liu H, Liu J, Haley KN, Treadway JA, et al.  Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotech. 2002;21:41–46
  47. http://www.probes.com/products/zenon

PII: S0304-3835(03)00632-3

doi: 10.1016/j.canlet.2003.08.030

Cancer Letters
Volume 206, Issue 2 , Pages 129-135 , 8 April 2004